Astellas Sued Over Efforts To Block Generic Prograf
The owners of a retail drug chain filed an antitrust class action Tuesday accusing Astellas Pharma US Inc. of abusing the U.S. Food and Drug Administration's drug approval process to delay...To view the full article, register now.
Already a subscriber? Click here to view full article